Table 1 Definitions of metabolic syndrome (MetS) by the MMRR, JCDCG and IDF diagnostic criteria.

From: Establishment and application of a new diagnostic definition of metabolic syndrome in the Shantou region of southern China

Components of MetS

MMRR

JCDCG

IDF

Men

Women

Men

Women

Men

Women

WC, cm

≥89

≥81

>90

>85

≥90

≥80

TG, mmol/L

≥1.73 or specific treatment of TG abnormality

≥1.64 or specific treatment of TG abnormality

≥1.70

≥1.70

≥1.7 or specific treatment of TG abnormality

≥1.7 or specific treatment of TG abnormality

HDL-C, mmol/L

≤1.07 or specific treatment of HDL-C abnormality

≤1.05 or specific treatment of HDL-C abnormality

<1.04

<1.04

<1.03 or specific treatment of HDL-C abnormality

<1.29 or specific treatment of HDL-C abnormality

BP, mmHg

SBP ≥ 138 or DBP ≥ 89 or treatment of previously diagnosed hypertension

SBP ≥ 136 or DBP ≥ 85 or treatment of previously diagnosed hypertension

SBP ≥ 130 or DBP ≥ 85

SBP ≥ 130 or DBP ≥ 85

SBP ≥ 130 or DBP ≥ 85 or treatment of previously diagnosed hypertension

SBP ≥ 130 or DBP ≥ 85 or treatment of previously diagnosed hypertension

FPG, mmol/L

 ≥ 5.8 or previously diagnosed type 2 diabetes

 ≥ 5.7 or previously diagnosed type 2 diabetes

 ≥ 6.1 or 2-h plasma glucose ≥ 7.8 or diagnosed diabetes

 ≥ 6.1 or 2-h plasma glucose ≥ 7.8 or diagnosed diabetes

 ≥ 5.6 or previously diagnosed type 2 diabetes

 ≥ 5.6 or previously diagnosed type 2 diabetes

Required

 ≥ 3 risk factors

 ≥ 3 risk factors

 ≥ 3 risk factors

 ≥ 3 risk factors

central obesity plus ≥ 2 other risk factors

central obesity plus ≥ 2 other risk factors

  1. MMRR, multivariate medical reference range; JCDCG, Chinese Joint Committee for Developing Chinese Guidelines; IDF, International Diabetes Federation; WC, waist circumference; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; SBP/DBP, systolic/diastolic blood pressure; FPG, fasting plasma glucose.